We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+4.23%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$910M
AUM Growth
+$303M
(+50%)
Cap. Flow
+$298M
Cap. Flow
% of AUM
32.79%
Top 10 Holdings %
Top 10 Hldgs %
6.34%
Holding
2,256
New
789
Increased
455
Reduced
377
Closed
581
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXGXU
GX Acquisiton Corp. Unit
GXGXU
|
+$2.63M |
| 2 |
LCAHU
Landcadia Holdings II, Inc. Unit
LCAHU
|
+$2.3M |
| 3 |
HYACU
Haymaker Acquisition Corp. II Unit
HYACU
|
+$1.62M |
| 4 |
GIX.U
GigCapital2, Inc.
GIX.U
|
+$1.35M |
| 5 |
Sarepta Therapeutics
SRPT
|
+$1.35M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.76% |
| 2 | Consumer Discretionary | 1.21% |
| 3 | Technology | 1% |
| 4 | Financials | 0.87% |
| 5 | Industrials | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCMP
326
CALL
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $837K | 0.09% |
7,600
-1,900
| -20% | -$215K |
|
327
CALL
Dave & Buster's
PLAY
$343M
| $826K | 0.09% |
20,400
+10,000
| +96% | +$509K |
|
328
CALL
SS&C Technologies
SSNC
$17.8B
| $824K | 0.09% |
+14,300
| New | +$862K |
|
329
CALL
FTI Consulting
FCN
$4.82B
| $822K | 0.09% |
9,800
+800
| +9% | +$65.8K |
|
330
CALL
Cognizant
CTSH
$21.5B
| $818K | 0.09% |
+12,900
| New | +$846K |
|
331
CALL
Ionis Pharmaceuticals
IONS
$9.35B
| $816K | 0.09% |
12,700
+10,200
| +408% | +$721K |
|
|
BLUE
332
CALL
DELISTED
bluebird bio
BLUE
| $814K | 0.09% |
494
-162
| -25% | -$280K |
|
333
CALL
Cooper-Standard Automotive
CPS
$504M
| $811K | 0.09% |
+17,700
| New | +$844K |
|
334
PUT
Bausch Health
BHC
$1.65B
| $805K | 0.09% |
31,900
+26,500
| +491% | +$629K |
|
|
CMA
335
PUT
DELISTED
Comerica
CMA
| $799K | 0.09% |
11,000
+6,300
| +134% | +$468K |
|
336
CALL
Hormel Foods
HRL
$13.9B
| $799K | 0.09% |
+19,700
| New | +$799K |
|
337
CALL
CSX Corp
CSX
$98.6B
| $797K | 0.09% |
30,900
+19,500
| +171% | +$502K |
|
|
AXON
338
CALL
Axon Enterprise
AXON
$40.5B
| $796K | 0.09% |
12,400
+7,800
| +170% | +$509K |
|
339
CALL
Mercury Systems
MRCY
$6.2B
| $795K | 0.09% |
+11,300
| New | +$784K |
|
340
PUT
Green Dot
GDOT
$753M
| $792K | 0.09% |
+16,200
| New | +$882K |
|
|
RST
341
CALL
DELISTED
ROSETTA STONE INC
RST
| $789K | 0.09% |
34,500
+11,700
| +51% | +$282K |
|
342
CALL
Starbucks
SBUX
$118B
| $788K | 0.09% |
+9,400
| New | +$737K |
|
343
CALL
Tilray
TLRY
$479M
| $787K | 0.09% |
1,690
+1,540
| +1,027% | +$736K |
|
344
CALL
Warner Bros
WBD
$64.6B
| $786K | 0.09% |
+25,600
| New | +$744K |
|
345
CALL
Regions Financial
RF
$26.3B
| $781K | 0.09% |
52,300
+44,500
| +571% | +$657K |
|
346
CALL
Virtu Financial
VIRT
$5.2B
| $780K | 0.09% |
35,800
-9,200
| -20% | -$216K |
|
347
CALL
Credit Acceptance
CACC
$6B
| $774K | 0.09% |
1,600
-3,600
| -69% | -$1.71M |
|
|
ARRY
348
CALL
DELISTED
Array Biopharma Inc
ARRY
| $774K | 0.09% |
16,700
+15,300
| +1,093% | +$430K |
|
|
MNCLU
349
DELISTED
Monocle Acquisition Corporation Units
MNCLU
| $772K | 0.08% |
75,000
-75,000
| -50% | -$763K |
|
|
XYZ
350
PUT
Block Inc
XYZ
$45.9B
| $762K | 0.08% |
10,500
+9,800
| +1,400% | +$685K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Walleye Capital held 2,256 positions worth $910M, up 50% from $607M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Walleye Capital deployed $298M of net new capital in Q2 2019, opening 789 new positions and adding to 455 existing holdings. Its largest new stake was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 1.3% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, an estimated $1.87M trimmed.
- Walleye Capital's largest Q2 2019 buy was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.
- Walleye Capital added most to Cronos Group in Q2 2019, an estimated $727K increase.
- Walleye Capital's biggest Q2 2019 reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, cutting an estimated $1.87M.
- Walleye Capital fully exited Pivotal Acquisition Corp. in Q2 2019, selling an estimated $1.27M.
- Walleye Capital's ten largest holdings make up 6.3% of its $910M portfolio in Q2 2019.
- Walleye Capital opened 789 new positions and closed 581 in Q2 2019.
- Walleye Capital's portfolio value rose 50% quarter-over-quarter to $910M.
Based on Walleye Capital's 13F filing for Q2 2019, filed 14 Aug 2019.